ArticleBlood2026

LCK-targeting molecular glues overcome resistance to inhibitor-based therapy in T-cell acute lymphoblastic leukemia.

Satoshi Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.